Albumin-Bound Paclitaxel (Celgene Corporation)

白蛋白结合型紫杉醇 (新基)

Report date: 2026/04/30 13:52:47

Base Information

Drug NameAlbumin-Bound Paclitaxel (Celgene Corporation)
Drug Alias NameNab-PaclitaxelCoraxaneCoroxaneSystemic nanoparticle albumin-bound paclitaxelAbraxane +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule inhibitors
TargetsTubulin
Therapy Area/IndicationsMetastatic breast cancerCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[7] 
Global Approved IndicationsMetastatic breast cancerBreast Neoplasms
Approved Indications in ChinaMetastatic breast cancer
Original Approved Country/TerritoryUnited States
Original Approved Date2005/01/07
Country/TerritoryUnited StatesUnited Arab EmiratesPeru +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCelgene CorpAbraxis Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Haichang Biopharmaceuticals Co LtdShantou University Medical CollegeTianjin Medical University Cancer Institute And Hospital +[9] 
Inactive CompaniesAbraxis BioScience LLC
Active IndicationsMetastatic breast cancerCarcinoma, Non-Small-Cell LungPancreatic Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A